2nd annual World Orphan Drug Congress – Geneva

The World Orphan Drug Congress is the industry-led Orphan Drug conference tackling global trends, market access and collaborations from big pharma, orphan specialists and patient organisations to impact rare diseases. View the 2011 full program for more about key speakers, workshops, strategic topics and industry leaders.


Come to The World Orphan Drug Congress 2011 and discover:

  • The international collaborative initiatives spurring the next generation of rare disease treatments
  • Best practice for achieving reimbursement and market access for your orphan drug
  • How to maximise the commercial potential of an orphan drug through expansion into multiple indications
  • The importance of patient partnerships to ensuring successful orphan drug development
  • New and cutting edge platforms for creating global rare disease patient registries
  • How to successfully translate research into approved rare disease treatments
  • Innovative case studies of clinical trials designed to overcome regulatory challenges of orphan drug approval

REGISTER now. You’ll come away with great new ideas to do better business.


Hear from an elite speaker faculty including leading executives from:

  • Pfizer
  • GSK
  • Genzyme
  • Prosensa
  • Amicus Therapeutics
  • Protalix
  • Shire HGT
  • Amsterdam Molecular Therapeutics
  • Celgene
  • Alexion Pharmaceuticals
  • PTC Therapeutics
  • Santhera Pharmaceuticals
  • Swedish Orphan Biovitrum
  • Genetic Alliance
  • Genethon
  • Rare Disease UK
  • AKU Society
  • euro-Ataxia
  • Behcet’s Syndrome Society
  • CheckOrphan
  • NIH
  • European Commission

If you need to know the latest innovations in these areas you must attend. REGISTER now



Starling Geneva Hotel & Conference Center (formerly known as the Crowne Plaza Hotel Geneva)

Route François-Peyrot 34

CH-1218 Le Grand Saconnex

Geneva • Switzerland

+41 22 747 02 02